4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-091442
Co-Chief Executive Officer sold 29,282 shares at $14.48 ($424,120)
From the SEC's structured data for this filing
Trades in this filing
Cohen Joshua B · Co-Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-02 | Sale : show line 1 in the form | −29,282 | $14.48 | $424,120 | 3,334,683 | D |
| Open-market sales · 29,282 sh · avg $14.48 · $424,120 | ||||||
Loading xslF345X05/ownership.xml…